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Abstract The target Rho GTPases of many guanine nucleotide
exchange factors (GEFs) of the Dbl family remain to be
identified. Here we report a new method: the yeast exchange
assay (YEA), a rapid qualitative test to perform a wide range
screen for GEF specificity. In this assay based on the two-hybrid
system, a wild type GTPase binds to its effector only after
activation by a specific GEF. We validated the YEA by
activating GTPases by previously reported GEFs. We further
established that a novel GEF, GEF337, activates RhoA in the
YEA. GEF337 promoted nucleotide exchange on RhoA in vitro
and promoted F-actin stress fiber assembly in fibroblasts,
characteristic of RhoA activation. ß 2000 Federation of Euro-
pean Biochemical Societies. Published by Elsevier Science B.V.
All rights reserved.
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1. Introduction
The Rho family of Ras-related GTPases comprises at least
15 distinct proteins that are key regulators of actin cytoskel-
eton dynamics also involved in a variety of cellular processes
[1,2]. Most Rho GTPases function as molecular switches os-
cillating between a GDP-bound inactive and a GTP-bound
active form [1]. The GTPase-activating proteins that stimulate
its intrinsic nucleotide hydrolysis activity regulate inactivation
of the GTPase. The release of GDP and binding of GTP are
catalyzed by guanine nucleotide exchange factors (GEFs). A
number of studies on Rho GTPase signaling have used con-
stitutively active mutant GTPases. Nevertheless, recent studies
have pointed out that the biological e¡ects elicited by these
non-cycling GTPases are not always consistent with those
obtained by activation of endogenous GTPases with the cor-
responding exchange factor [3^5]. The identi¢cation of Rho
GEFs and their target GTPases is an essential step in unrav-
eling Rho-dependent signaling pathways.
The Dbl-like GEFs have very high transforming potential,
as a consequence of the deregulated activation of Rho
GTPases and their downstream signaling pathways [6].
GEFs also play an important role in the cross talk between
the di¡erent Rho GTPase pathways [7^9] and in their con-
nection with other signaling cascades [6]. Rho GEFs are char-
acterized by the presence of a Dbl homology (DH) domain of
200 amino acids (aa) which harbors the guanine nucleotide
exchange activity and in many cases a pleckstrin homology
domain, implicated in intracellular membrane targeting of the
protein [6]. The sequences of over 40 putative Dbl-related
GEFs have been released in databases ranging from 400 to
over 6500 aa long [10,11]. The speci¢city of about half of
these GEFs was established. Some are speci¢c of a single
GTPase while others activate several ones [6]. Comparing
the aa sequences of the DH domains of the GEFs studied
so far did not lead to any obvious rule to deduce their
GTPase speci¢city [6,12]. The speci¢city of a new exchange
factor is usually established by in vitro guanine nucleotide
exchange assays. One major limitation of this method is the
puri¢cation of active exchange factors and GTPases, which in
some instances cannot be achieved [13].
Here we present the YEA (yeast exchange assay), a new
functional assay in yeast based on the two-hybrid interaction
system, which allows a quick initial screen for the activity of
Dbl-related GEFs on a wide range of Rho-related GTPases.
With the YEA, we were able to reproduce the activation of
Rac1, RhoG, Cdc42Hs and RhoA by Tiam-1 [14], Trio D1
[15], KPIX [16] and Trio D2 [17], respectively. We further
studied GEF337, a putative Dbl-related exchange factor
from the HUGE cDNA database [18]. In the YEA, we dem-
onstrate that GEF337 activates RhoA. We con¢rmed this
result by in vitro guanine nucleotide exchange assays. Finally,
we establish that GEF337 induces the assembly of actin stress
¢bers when overexpressed in ¢broblastic cells, demonstrating
that it does activate RhoA in vivo.
2. Materials and methods
2.1. Plasmid construction
The LexA and GAL4 constructs have been described elsewhere [19].
pGEX-RhoA and pRK5-mycRhoAV14 were gifts from A. Hall (Lon-
don, UK) and pCEV-RhoG a gift from X. Bustelo (Stoney Brook,
NY, USA). The catalytic regions of Trio (D1: aa 1232^1429 and D2:
aa 1849^2450) [20], KPIX (aa 60^779) [16] and Tiam-C580 (aa 1011^
1591) [14] were fused to the HA- (Trio D2) or myc- (others) tag and
inserted into the yeast expression vector pRs426Met [21]. KIAA0337
is a cDNA from the HUGE database from the Kazusa sequencing
project (accession number AB002335). The DH domain and full
length open reading frame (respectively nucleotides 1802^3031 and
nucleotides 534^6288) of KIAA0337 were fused to the myc-tag and
inserted in pRs426Met or pRcCMV (Invitrogen). The DH domain
was fused to GST in pGEX (Pharmacia).
2.2. Yeast techniques
Interactions were assayed in yeast strain TAT7 (Mata, trp1, his3,
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leu2, ura3, ade2, LYS: :(LexAop)4-HIS3, URA3: :(LexAop)8-lacZ),
provided by J. Camonis (Paris, France). Filter assays were performed
as described [19]. For histidine (HIS) auxotrophy assays, yeasts were
spotted on the appropriate drop out (DO) plates lacking HIS and
supplemented with the indicated amount of 3-aminotriazole (3-AT).
Quantitative determinations of L-galactosidase activities were per-
formed as described [15]. The basal L-galactosidase activity (A,
nmol/min/mg) was calculated according to the formula A = 20U1.7
OD405/0.0045 T, where 1.7 corrects for the reaction volume and 20
for the amount of protein, 0.0045 is the optical density of a 1 nmol/ml
solution of ONPG and T the time in minutes. Activation of L-galac-
tosidase was then expressed as a fold increase of the basal activity.
The yeast cdc24ts strain 12.2 was obtained by mating TAT7 to
YMP483, bearing the cdc24-5 ts (thermosensitive) mutation [22]. Dip-
loids were selected, allowed to sporulate and individual spores were
selected for the presence of both the lacZ reporter expression cassette
and the cdc24ts mutation. 12.2 strain was grown at 25‡C and the L-
galactosidase assays performed as in TAT7.
2.3. GDP release assay
GST fusion proteins were expressed in Escherichia coli, GTPases
loaded with [3H]GDP and exchange performed as described [15].
Brie£y, 25 pmol of exchange factor and [3H]GDP-loaded GTPase
were mixed in 80 Wl of reaction bu¡er (50 mM Tris pH 7.5, 1 mM
GTP, 2 mM MgCl2) and incubated at 20‡C. The fraction of
[3H]GDP-bound GTPase was determined after 0, 1, 2, 5, 10 and 15
min of reaction.
2.4. Cell culture, transfection and immuno£uorescence
Rat embryo ¢broblasts (REF-52) were cultured, transfected and
processed for immuno£uorescence as described [15]. The myc-tagged
proteins with 9E10 anti-myc monoclonal antibody followed by incu-
bation in biotin-conjugated sheep anti-mouse IgG (1:200 dilution,
Amersham) and then streptavidin FITC (1:200 dilution, Amersham).
Actin was stained using rhodamine-conjugated phalloidin (0.5 U/ml,
Sigma). Cells were observed under a DMR Leica microscope using a
63U planapochromat lens. Images were recorded using a micromax
1300Y/HS camera (Princeton Instruments Inc., USA) using the Meta-
morph acquisition software, transferred to Adobe Photoshop and
printed on an Epson Color 750 printer. All transfections were re-
peated at least three times and at least 100 transfected cells were
examined.
2.5. Bio-computing
Search for consensus protein domains in GEF337 protein sequence
was performed with the Pfam program (http://pfam.wustl.edu/
hmmsearch.shtml) [23] and DH domain of GEF337, ABR and BCR
were aligned using MULTALIN [24].
3. Results
3.1. Establishment of YEA
We wanted to develop a functional assay in yeast, which
Fig. 1. Interaction of Rac1, RhoG, Cdc42Hs and RhoA GTPases
with their e¡ectors in the two-hybrid system. A: Filter assay for L-
galactosidase activity in TAT7 yeasts expressing the constitutively
active (DA) or wt (WT) GTPases fused to LexA DNA binding do-
main and their e¡ector proteins fused GAD. B: The same yeasts
were assayed for the transactivation of the HIS3 reporter gene by
growth on DO plates lacking HIS and supplemented with 20 mM
3-AT in the case of Cdc42Hs.
Fig. 2. Activation of the binding of wt GTPases to their e¡ectors
by expression of a positive exchange factor. A: L-Galactosidase ac-
tivity in TAT7 yeasts expressing wt GTPases fused to LexA, their
e¡ectors fused to GAD and the indicated positive (+) or negative
control (3) GEFs or the pRs vector alone (c). B: Transactivation
of the HIS3 reporter gene by growth on DO plates lacking HIS
supplemented with 5 mM 3-AT. C: The L-galactosidase activity was
measured by ONPG liquid assay using 5 Wg total protein extracts
from yeasts expressing positive (+) or negative (3) GEFs, and ex-
pressed relative to the basal activity in yeasts expressing no ex-
change factor (c). Inset: basal L-galactosidase activity (nmol/min/
mg) in 5 Wg total protein extracts from yeast expressing no exchange
factor (c). Reactions were performed for 3 h at 30‡C. Mean and
S.E.M. of three experiments are shown. D: ONPG liquid assay in
cdc24ts strain 12.1. Inset: L-galactosidase activity in 12.1 yeasts ex-
pressing wt Cdc42Hs, its e¡ector PAK and KPIX positive (+) or
Trio D1 negative control (3) GEFs or the pRs vector alone (c).
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would provide a quick test to screen for the speci¢city of
newly identi¢ed GEFs. In the classical two-hybrid protein
interaction assay, a dominant active (DA) mutant Rho
GTPase fused to the LexA DNA binding domain (LexA)
can interact with its e¡ector fused to GAL4-activating domain
(GAD). This interaction leads to the assembly of a transcrip-
tionally active complex driving the expression of lacZ and
HIS3 reporter genes. In the same assay, the wild type (wt)
GTPase does not bind to its e¡ector. In yeasts expressing a
wt GTPase and its e¡ector, we further introduced a third
plasmid expressing the catalytic DH domain of an exchange
factor. We postulated that a speci¢c exchange factor should
activate its target GTPase and allow its binding to its e¡ector
thereby leading to the transactivation of the reporter genes.
When we expressed LexA-Rac1G12V, RhoGG12V,
Cdc42HsG12V and RhoAG14V in TAT7 yeast strain, these
DA mutant GTPases bound to their respective GAD-fused
targets (Fig. 1): kinectin as a target of Rac1 and RhoG,
PAK1 for Cdc42Hs and Rock for RhoA [19]. In the case of
Rac1 and RhoG, the wt GTPases showed no binding to kine-
ctin (Fig. 1) while wt RhoA, and to a larger extent wt
Cdc42Hs, exhibited a higher basal binding activity to their
e¡ectors. Nevertheless, the DA RhoAG14V and Cdc42HsG12V
bound more e⁄ciently to their e¡ectors than the wt GTPases
(Fig. 1).
We further transformed yeasts expressing the wt GTPases
and their respective e¡ectors with the previously characterized
positive exchange factors: Tiam-1 for Rac1 [14], Trio D1 for
RhoG [15], KPIX for Cdc42Hs [16] and Trio D2 for RhoA
[17]. The catalytic domains of these proteins were expressed as
myc-tagged (Tiam-1, Trio D1 and KPIX) or HA-tagged (Trio
D2) proteins and the transactivation of HIS3 and lacZ report-
er genes was assayed.
In the case of Rac1, RhoG and RhoA, we did observe
increased L-galactosidase activity in ¢lter assays and growth
on HIS selection medium (Fig. 2A,B) in yeasts co-expressing a
positive exchange factor (+ lanes): Rac1 and RhoG bound
kinectin and RhoA bound Rock, upon Tiam-1, Trio-D1 and
Trio D2 expression, respectively. Thus the wt GTPases Rac1,
RhoG and RhoA were activated and now able to bind their
e¡ector proteins. In the case of Rac1 and RhoG, no activity
was observed in the absence of an exchange factor (c lanes),
or when a negative control exchange factor (KPIX) was ex-
pressed (3 lanes). In the case of RhoA, the basal binding of
the wt GTPase to Rock was higher than in the two-hybrid
experiments (Fig. 1), due to the fact that the GTPase activa-
tion experiments needed to be run longer to obtain positive L-
galactosidase activities and growth on HIS medium similar to
the two-hybrid interaction assays. We then measured the in-
crease in L-galactosidase activities after expression of a pos-
Fig. 3. A novel putative exchange factor from the Dbl family. A: Localization of the DH (gray box) domain in GEF337 as identi¢ed by the
Pfam pro¢le scanning server (St. Louis). Percent refers to the identity to the DH domain of Dbl. Further information on KIAA0337 is avail-
able at http://www.kazusa.or.jp. B: Alignment of the DH domains of GEF337, ABR and BCR. Sequences aligned using the MULTALIN pro-
gram. !: I or V, $: L or M, %: F or Y and #: N, D, Q, E, B or Z.
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itive GEF using a quantitative colorimetric assay and con-
¢rmed the above results: the expression of a positive exchange
factor markedly increased the basal L-galactosidase activity,
while a negative control GEF had no e¡ect (Fig. 2C).
In the case of Cdc42Hs, the basal L-galactosidase activity
was very high as compared to the other GTPases, therefore
we did not observe any clear increase in the binding of
Cdc42Hs to PAK upon expression of the positive GEF
KPIX (Fig. 2A^C). As the high basal L-galactosidase activity
we observed in this assay was most likely due to the activation
of Cdc42Hs by yeast Cdc24p [25], we performed the YEA on
Cdc42Hs in the yeast strain 12.2 bearing a cdc24ts mutation.
In this strain, we did observe L-galactosidase activity induc-
tion in ¢lter assays (Fig. 2D, inset) in yeasts co-expressing the
positive exchange factor KPIX (+ lane), while no activity was
observed in the absence of an exchange factor (c lane), or
when a negative control exchange factor (Trio D1) was ex-
pressed (3 lane), which was con¢rmed by the quantitative
colorimetric assay (Fig. 2D).
This new functional assay termed as YEA thus appears as a
convenient qualitative test suitable to screen for the speci¢city
of di¡erent Dbl-related exchange factors towards various Rho
GTPases. We then further used the YEA method to assay for
an exchange factor of unknown speci¢city.
3.2. GEF337 behaves as RhoA exchange factors in the yeast
functional assay
KIAA0337 is a human cDNA from the HUGE cDNA da-
tabase [18] that encodes a Dbl-like protein referred to as
GEF337 (Fig. 3A). The DH domain of GEF337 is closer to
that of Bcr (29 and 35% identity, respectively) and Abr (28
and 30%) (Fig. 3B), both reported to act as GEFs for RhoA,
Rac1 and Cdc42Hs in vitro [26].
We used the YEA method to determine the GTPase specif-
icity of this novel exchange factor. The DH domain (DH337)
and full length GEF337 were fused to the myc-tag and trans-
formed in yeasts TAT7 already expressing wt RhoA, RhoG or
Rac1 and their respective e¡ectors, as well as in 12.2 yeasts
expressing wt Cdc42Hs and PAK. DH337 e⁄ciently activated
RhoA and to a lesser extent RhoG, but did not activate Rac1
or Cdc42Hs (Fig. 4A). The increase in L-galactosidase activity
was over 4-fold in the case of RhoA while it was only 1.5-fold
for RhoG (Fig. 4B). The expression of the full length GEF337
in yeast did not activate RhoG any longer, while maintaining
the same level of activity on RhoA as DH337 (Fig. 4A,B).
The use of the YEA method therefore suggests that GEF337
is an exchange factor speci¢c for RhoA.
3.3. KIAA0337 can catalyze GDP exchange on RhoA in vitro
To con¢rm the results obtained in yeast, we performed in
vitro exchange assays using puri¢ed proteins. DH337, RhoA
and RhoG GST fusions were a⁄nity-puri¢ed from bacteria.
The GTPases were loaded with [3H]GDP and incubated with
an equimolar amount (300 nM) of DH337. The fraction of
GDP-bound GTPase was determined after 0, 1, 5, 10 and 15
min of reaction. After 15 min in the presence of DH337,
RhoA had released more than 90% of its bound [3H]GDP
(Fig. 5, black circles), while RhoG was still stably bound to
GDP (Fig. 5, black squares). In similar experimental condi-
tions, we obtained as much as 90% guanine nucleotide ex-
change on RhoG, using Trio D1 as an exchange factor (not
shown, see [15]). As a control for the stability of the GDP-
loaded RhoA GTPase, GST was used instead of the exchange
Fig. 4. Activation of wt GTPases upon expression of GEF337. A:
The wt GTPase, their e¡ectors and the DH domains (DH) or full
length (GEF) GEF337 were expressed in TAT7 or 12.1 (Cdc42Hs).
The transactivation of the HIS3 (TAT7) and of the L-galactosidase
(12.1) reporter genes was assayed as in Fig. 2. B: The L-galactosi-
dase activities determined with an ONPG liquid assay as in Fig. 2.
Mean and S.E.M. of three experiments are shown.
Fig. 5. GEF337 speci¢cally promotes GDP/GTP exchange on
RhoA. [3H]GDP-loaded GST-fused RhoA and RhoG (300 nM)
were incubated in the presence of GST-fused DH337 (300 nM) or
GST (1 mM) and cold GTP (1 mM). Mean and S.E.M. from three
experiments are shown.
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factor. In this case, RhoA remained stably bound to [3H]GDP
(Fig. 5, open circles).
As expected from the YEA results, DH337 e⁄ciently pro-
moted guanine nucleotide exchange on RhoA, but was not
active on RhoG in vitro. To con¢rm the activity of GEF337
on RhoA, we further studied this putative RhoA activator in
cultured cells.
3.4. GEF337 induces actin stress ¢ber assembly in ¢broblasts
Activation of RhoA triggers actin stress ¢ber assembly in
cultured ¢broblastic cells [27]. To examine whether GEF337
could act as a RhoA exchange factor in vivo, we expressed
this protein as myc-tagged fusion in exponentially growing rat
embryo ¢broblasts (REF-52). The resulting modi¢cations in
the actin containing structures were then examined with rhod-
amine-labeled phalloidin 24 h after transfection.
When myc-tagged full length GEF337 was expressed in
REF-52 ¢broblasts, 60^80% of the transfected cells exhibited
a contracted morphology associated with an increase in actin
stress ¢ber content (Fig. 6c,d) similar to what was observed
upon RhoAG14V expression (Fig. 6a,b). They did not induce
¢lopodia or microvilli formation, characteristic of Cdc42Hs
and RhoG activation or the apparition of lamellipodia or
ru¥es, characteristic of Rac1 and RhoG activation [19]. In
REF-52 cells, expression of GEF337 thus induced RhoA
but not Cdc42Hs, Rac1 or RhoG activation. Similar results
were obtained in Swiss 3T3 mouse ¢broblastic cells (not
shown). Combined with the results from YEA and in vitro
exchange assays, these data con¢rm that GEF337 acts as a
speci¢c in vivo RhoA exchange factor.
4. Discussion
We report in this study a new functional assay termed YEA
which provides a rapid test to perform wide range screens for
GEFs speci¢city towards many GTPases. This assay, based
on the classical two-hybrid system, has been designed to de-
tect the activation of a wt GTPase by an exchange factor. The
activation of the GTPase is revealed through its interaction
with its e¡ector, as in a classical two-hybrid system. The YEA
proved successful to con¢rm the speci¢city of various GEFs
previously established under di¡erent experimental conditions.
We further studied a novel putative Dbl-related exchange fac-
tor: GEF337. We could demonstrate that GEF337 speci¢cally
activates RhoA using the YEA. Consistently, it catalyzes gua-
nine nucleotide exchange on RhoA in vitro and when overex-
pressed in ¢broblasts, GEF337 induced the assembly of actin
stress ¢bers, characteristic of RhoA activation.
Dbl-related GEFs are key regulators of Rho-related
GTPase signaling pathways, involved in many biological pro-
cesses from oncogenic transformation to neuronal develop-
ment [6]. Several complementary experimental approaches
have been used to study the catalytic activity of exchange
factors. In vitro guanine nucleotide exchange assays using
puri¢ed proteins allow a biochemical analysis of the exchange
reaction. In vivo, the ectopic expression of an exchange factor
induces the activation of endogenous GTPases. The activation
can be monitored by pulling down the activated GTPases
using their e¡ectors as a bait [28] or through the biological
e¡ects elicited by these GTPases, such as actin cytoskeleton
reorganization or kinase activation. Nevertheless, both types
of approaches su¡er several limitations. In vitro exchange
assays require prior puri¢cation of active proteins. This step
proved critical for GTPases and GEFs, many of which have
been reported to be poorly functional proteins, because of
insolubility and non-proper folding [13]. Besides, although
in vivo analysis of GEF activity might overcome this problem,
¢nal interpretation might be misleading due to cross talk be-
tween di¡erent Rho GTPases: for instance Cdc42Hs activates
Rac1 [29] and RhoG activates Rac1 and Cdc42Hs [19], which
Fig. 6. GEF337 induces stress ¢ber assembly in ¢broblasts. REF-52 cells were transfected with constructs expressing myc-tagged GEF337 or
RhoAG14V : myc epitope expression (a and c) and F-actin distribution (b and d). Bar: 10 Wm. For each panel, cells shown are representative of
more than 100 observed cells from at least three transfection experiments.
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makes it di⁄cult to readily establish GEF speci¢city in vivo.
Finally, both methods are tedious to study a large number of
GEFs and GTPases. As a consequence, most GEF speci¢cities
have been mainly assayed on Rac1, RhoA and Cdc42Hs,
while the other Rho GTPases have never or scarcely been
tested [1,6]. The YEA method we describe here provides a
complementary approach based on cDNA cloning which al-
lows large scale studies. Furthermore, this method is partic-
ularly suitable for site-directed mutagenesis analyses to iden-
tify residues critical for the activity of a GEF towards a given
GTPase. Finally, the YEA can easily be adapted to assay for
the activation of the other GTPases from the Ras superfamily.
The design of the YEA was motivated by many earlier
studies where the two-hybrid system was successfully used
to study the interaction of active mutant GTPases with their
e¡ectors. We validated the YEA using exchange factors of
known speci¢city. A limitation of the YEA is the basal level
of activation of some GTPases, probably due to endogenous
yeast exchange factors. The mammalian GTPase RhoA is
possibly activated by the yeast exchange factors Rom1p and
Rom2p, which activate Rho1p, a yeast GTPase that is 70%
similar to RhoA. Rom2p has indeed been shown to activate
RhoA in vitro [30]. Notwithstanding the basal RhoA activity,
ectopic expression of positive exchange factors led to a readily
detected increase in RhoA activation. In the case of Cdc42Hs,
the high basal activity due to the yeast exchange factor for
Cdc42p [25] was suppressed by working in a cdc24ts strain,
which allowed the detection of Cdc42Hs activation by exoge-
nous GEFs.
Using the YEA, we found that the novel Rho exchange
factor GEF337 displayed exchange speci¢city for RhoA.
GEF337 can directly catalyze guanine nucleotide exchange
in vitro and when expressed in REF-52 and Swiss 3T3 ¢bro-
blastic cells GEF337 indeed triggered actin stress ¢ber assem-
bly, a characteristic of RhoA activation. The catalytic domain
DH337, but not the full length GEF337, slightly activated
RhoG in the YEA, which was not con¢rmed in vitro and in
vivo. This suggests that the YEA might be in some instances
either less stringent or more sensitive than the other methods.
For instance, Trio D1 e⁄ciently activates both RhoG and
Rac1 in the YEA (our unpublished data), while it is 10-fold
more active on RhoG than on Rac1 in vitro and speci¢cally
activates RhoG in vivo [15]. The above observations clearly
stress out the necessity of using complementary approaches to
investigate the catalytic speci¢city of any novel exchange fac-
tors.
The regulation of the di¡erent Rho pathways in vivo is still
poorly understood. However, their cross talk must be ¢nely
regulated to ensure a correct control of cell morphology, ad-
hesion and movement [31]. GEFs most likely play a crucial
role in coordinating spatial and temporal activation of
GTPase signaling cascades. The new challenge in Rho
GTPase study is now to identify their cellular and physiolog-
ical functions. This will require the ability to activate the
endogenous proteins, rather than using DA mutants, which
may not mimic the ¢ne regulation of a cycling GTPase. A
crucial step therefore resides in the study of Dbl-related ex-
change factors, the upstream regulators of Rho-related
GTPase. They exhibit high tissue speci¢city and possess multi-
ple regulatory domains, which allow a tight regulation of
GTPase activation both in time and space as well as the cross
talk of Rho pathways with many other signaling cascades.
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